Which drugs does patent 6,555,133 protect, and when does it expire?
Patent 6,555,133 protects SUSTIVA and is included in one NDA. There have been two Paragraph IV challenges on Sustiva.
Protection for SUSTIVA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-two patent family members in twenty-six countries.